No Data
Super Value: Notice regarding the recording of extraordinary losses, differences between full-year earnings forecasts and actual values, and dividends from surplus
Super Value: Summary of financial results for the fiscal year ending February 2025 [Japanese GAAP] (unconsolidated)
Super Value FY Parent Loss Y2.79B Vs Loss Y2.26B
Cosmos Pharmaceutical, Asterisk, Asahi Chemicals, Takashimaya (14th)
※ The above Calendar is merely a schedule and is subject to change due to the company's circumstances.--------------------------------------- April 14 (Monday) <135A> VRAIN <138A> Hikari Food Service <1407> West HD <1418> Interlife <1430> 1st Corp <1434> JESCO HD <156A> Material G <
BOJ Seeks More Rate Hikes but Not in Rush, Deputy Governor Says -- 2nd Update
Super Value: Summary of financial results for the 3rd quarter of the fiscal year ending February 2025 [Japanese GAAP] (unconsolidated)
